BPA for iclusig
Active Awarded Last action
- Contract number
- 36E79726A0002
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI ENNFDLWFC6L1
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 53% complete
- IDV ceiling
- $43,845,764.75
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The National Acquisition Center established a Blanket Purchase Agreement with Takeda Pharmaceuticals America, Inc., on October 4, 2025, with a ceiling of $43,845,764.75 and an ultimate completion date of October 3, 2027. The BPA is established against the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), which provides a framework for pharmaceutical commodity procurement across federal agencies.
The BPA procures ICLUSIG (ponatinib), a specialty oncology pharmaceutical for chronic myeloid leukemia and acute lymphoblastic leukemia, in multiple tablet strengths from 10 milligram through 45 milligram. Place of performance is Earth City, Missouri and Cambridge, Massachusetts, with ordering performed by the Department of Veterans Affairs VISNs and the Federal Correctional Complex Florence.
Recent ordering activity under this BPA reflects pharmaceutical commodity patterns, with delivery orders typically ranging from $13,000 to $43,000. VA purchasing entities account for the totality of spending, with Veterans Integrated Service Network 20 as the highest-volume purchaser by award count (40 awards, $2.7 million combined potential value), followed by VISN 5 (35 awards, $557,000) and VISN 9 (27 awards, $345,000). The Federal Correctional Complex Florence placed seven orders valued at $129,000 combined. Orders cover ICLUSIG in various strengths and continue to support foundation care pharmaceutical chemotherapy protocols across the VA system.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79726A0002?
36E79726A0002 was awarded to Takeda Pharmaceuticals America, Inc. by National Acquisition Center (Headquarters) on October 4, 2025.
How much is contract 36E79726A0002 worth?
36E79726A0002's own ceiling is $43,845,765.
Who can order from contract 36E79726A0002?
36E79726A0002 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79726A0002 under another contract?
Yes. 36E79726A0002 is a blanket purchase agreement under 36F79725D0180, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79726A0002 competed?
The extent of competition for 36E79726A0002 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV